Immune escape of tumors: apoptosis resistance and tumor counterattack.
about
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cellsHedgehog signaling: modulation of cancer properies and tumor mircroenvironmentEmerging role of Toll-like receptor 4 in hepatocellular carcinomaLung cancer vaccinesEnhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in miceImmunosuppressive strategies that are mediated by tumor cellsEnhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsRelating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational researchApoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancerNeem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells.Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancerDigital genomic quantification of tumor-infiltrating lymphocytes.Modifying Dendritic Cell Activation with Plasmonic Nano VectorsPrognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer.Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.Immunotherapy of human cancers using gene modified T lymphocytes.Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expressionModeling putative therapeutic implications of exosome exchange between tumor and immune cells.PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrolGain of HIF-1α under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes.Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosisFunctional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.Toll-like receptor 4 activation in cancer progression and therapyPotent and tumor specific: arming bacteria with therapeutic proteins.Immunosuppressive tumor microenvironment in cervical cancer patientsThe development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccineTissue-specific inactivation of murine M6P/IGF2R.Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis.Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme InhibitorsCannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsNew benzimidazole acridine derivative induces human colon cancer cell apoptosis in vitro via the ROS-JNK signaling pathway.Anti-cancer effect of Annona Muricata Linn Leaves Crude Extract (AMCE) on breast cancer cell lineA Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.DNA vaccines, electroporation and their applications in cancer treatmentMC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer modelApoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis.Proprotein convertase inhibition: Paralyzing the cell's master switches.VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
P2860
Q24681974-CB5AFF9F-8B16-4890-84B9-4AA4EAB675E2Q26764740-CB31DB5A-5C1A-4BDE-B124-C63339272DF7Q26824613-CD0B8ED2-1D0C-4B38-B1A5-191F3C0812B0Q27014375-F9595AE5-D3F6-4139-A9B9-06159991C6F4Q28543176-5D6AB9BC-4C12-4FF5-BC44-B170E9EB5720Q29636247-2A3D08CF-0C47-43E2-A828-4596E641FAB1Q30408302-0C6B1606-E252-4E3D-AB9D-B75037C6E0E6Q30965534-7A0E2C51-6302-4ACF-BB71-AFC6E4322628Q33327764-81DCFBC1-0A8D-4317-A893-84ACE85F3EA7Q33570507-87D3F71D-879B-40CE-B357-2C1E04F4E3D0Q33599462-E4383345-48D7-41A0-963F-7EB195C23B16Q33602876-883575E2-8750-4ED1-A953-E17CF732BA97Q33631158-19AE1D02-F41B-41FC-AE3E-1012FE9499E1Q33906222-F8AFD215-ECB3-42E8-92FB-160954BCECA8Q33959522-4A3F30CF-B929-476D-BE2B-59E461A30B3CQ34166515-9DF4867B-224F-452D-B5B9-76B5D63C5ADEQ34188383-1270F625-27C6-41CF-952F-3A67A8D98AC1Q34297762-86A9B524-A7DC-456A-91C0-F77B22CB7AB3Q34407541-6BBBFEB7-5F8F-4237-AFD2-4EAADE7084E7Q34649457-8F9A14A4-B420-4452-AEBE-7E0C917DCD97Q34870725-07BC1FF9-D34E-4AFB-98B7-B90808E49B85Q35178345-3DEE5A0C-A5CF-485C-BA47-9259B879A420Q35223578-FE41E870-E03B-4495-83BF-BA01FC157928Q35448446-89235A66-99B1-40E3-8D91-2AF3F710726CQ35550677-843344A9-48BF-47B0-8776-3F3F7CDDF8C0Q35579375-88EC4400-06EF-47B2-BE90-EB22929C0AB4Q35603131-99AFF4B7-8D88-47BA-8E47-9D2479743C79Q35623444-0825508E-963E-4C65-A65C-65EAC39455CFQ35748838-575F5A5D-A131-4F39-8586-8DDA47D933EFQ35837020-936385CD-7F71-4C9F-8548-5E7CCE514E70Q35952443-3A93E068-169F-4136-93B6-FDF804EE4A88Q36021048-DA82FFB0-1B1B-4FC8-A6A6-C2ED20719A75Q36034242-4F1C8D1B-6DD6-45F1-9926-B8F3AA5339A2Q36112190-F969303E-363C-44BD-94DC-362ED850C008Q36188919-214FCB71-3EF3-4CDC-8F1F-60951913367DQ36256459-C654CB2B-7F4B-44BE-8C06-C24429A93E63Q36256568-0CBD42E6-D25C-4F90-9738-CFA65B6FA996Q36322609-9D9D2098-6B7C-4213-818D-968FF9CAB0BDQ36358957-53C6696F-C397-4A60-B319-706C4E9BC764Q36419140-D76D6562-1D13-4C58-984B-9E089560ACFB
P2860
Immune escape of tumors: apoptosis resistance and tumor counterattack.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@ast
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@en
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@nl
type
label
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@ast
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@en
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@nl
prefLabel
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@ast
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@en
Immune escape of tumors: apoptosis resistance and tumor counterattack.
@nl
P1476
Immune escape of tumors: apoptosis resistance and tumor counterattack
@en
P2093
Frederik H Igney
Peter H Krammer
P304
P577
2002-06-01T00:00:00Z